Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
To assess the tolerability and effectiveness of rabbit antithymocyte globulin (ATG,
Thymoglobuline) with ciclosporin in the first line treatment of patients with acquired severe
aplastic anaemia, and patients with non-severe aplastic anaemia and who are transfusion
dependent.
Phase:
Phase 2
Details
Lead Sponsor:
European Group for Blood and Marrow Transplantation European Society for Blood and Marrow Transplantation